Subject to certain limits under California law, California residents may ask us to provide them with (1) a list of certain categories of personal information we have disclosed to third parties for their direct marketing purposes during the immediately preceding calendar year, and (2) the identity of those third parties. To make this request, California residents may contact us as specified in the "How To Contact Us" section at the bottom of the Privacy Notice Page.
6165 Barfield Road
Atlanta GA, 30328
Tel: +1 (770)688-1206
Fax: +1 (770)688-1229
FDA has issued a final rule on the safety and effectiveness of certain antibacterial soaps. The final rule established that over-the-counter consumer antiseptic wash products contained certain active ingredients that can no longer be marketed. "Companies will no longer be able to market antibacterial washes with these ingredients because manufacturers did not demonstrate that the ingredients are both safe for long-term daily use and more effective than plain soap and water in preventing illness and the spread of infections," stated an article by the FDA. There are 19 ingredients addressed in this ruling. Some manufacturers have already begun the process of removing these ingredients from their products.
An announcement was published on July 29, 2020 that user fees within the Consolidated Omnibus Budget Reconciliation Act (COBRA) will take place effective October 1, 2020. The minimum merchandise processing fee will change from $26.79 to $27.23 and the maximum will change from $519.76 to $528.33. The ad valorem rate of 0.3464% will not change. Additional user fees are also increasing.
The Office of the U.S. Trade Representative has announced that 14 products from the Section 301 exclusion list scheduled to expire July 31st will continue to be excluded through December 31, 2020. Additionally, there are other products on the list that expired on July 31st. Comments are currently being accepted for three sets of exclusions that are scheduled to expire October 2, 2020. Comments can be submitted by clicking HERE
On July 14, 2020, the President signed an Executive Order that requires Hong Kong to be treated as the People’s Republic of China (PRC) for the purposes of the Arms Export Control Act (AECA). Hong Kong is now considered to be included in the entry for China under section 126.1(d)(1) of the ITAR and therefore subject to a policy of denial for all transfers subject to the ITAR. The U.S. government is taking this action because the Chinese Communist Party has fundamentally undermined Hong Kong’s autonomy and thereby increased the risk that sensitive U.S. items will be illegally diverted to the PRC.